These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 3018469

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Leads from the MMWR. Human T-lymphotropic virus type III/lymphadenopathy-associated virus: agent summary statement.
    JAMA; 1986 Oct 10; 256(14):1857, 1861, 1868 passim. PubMed ID: 3020262
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody testing at alternate sites.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1986 May 02; 35(17):284-7. PubMed ID: 3010070
    [Abstract] [Full Text] [Related]

  • 5. Update: evaluation of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection in health-care personnel--United States.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1985 Sep 27; 34(38):575-8. PubMed ID: 2993842
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1985 Nov 15; 34(45):681-6, 691-5. PubMed ID: 2997587
    [No Abstract] [Full Text] [Related]

  • 9. Agent summary statement for human immunodeficiency viruses (HIVs) including HTLV-III, LAV, HIV-1, and HIV-2.
    Centers for Disease Control (CDC).
    MMWR Suppl; 1988 Apr 01; 37(4):1-17. PubMed ID: 2832719
    [No Abstract] [Full Text] [Related]

  • 10. [Guidelines for the management of patients infected by the human immunodeficiency virus].
    Ponce de León S, Ruiz-Palacios GM.
    Rev Invest Clin; 1988 Apr 01; 40(1):47-63. PubMed ID: 3165542
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody prevalence in U.S. military recruit applicants.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1986 Jul 04; 35(26):421-4. PubMed ID: 3014305
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety issues raised by worker's infection with AIDS virus.
    Palca J.
    Nature; 1986 Jul 04; 329(6136):191. PubMed ID: 3627260
    [No Abstract] [Full Text] [Related]

  • 16. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Centers for Disease Control, U.S. Department of Health and Human Services.
    Ann Intern Med; 1986 Aug 04; 105(2):234-7. PubMed ID: 3014942
    [Abstract] [Full Text] [Related]

  • 17. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG, Ponce de León S, Ruiz Palacios G, Tinoco JC, Calva JJ, Zamora EE.
    Salud Publica Mex; 1986 Aug 04; 28(2):180-5. PubMed ID: 3014666
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.